Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: Impact of the duration of therapy

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 6, 2009, Pages 549-555

  Camus, Christophe ^a   Lavoué, Sylvain ^a   Gacouin, Arnaud ^a   Compagnon, Philippe ^a   Boudjéma, Karim ^a   Jacquelinet, Christian ^b   Thomas, Rémi ^a   Le Tulzo, Yves ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Biomedicine Agency   (France)

Author keywords

Fulminant hepatic failure; Liver transplantation; Molecular adsorbent recycling system albumin dialysis

Indexed keywords

HEPARIN; PARACETAMOL;

ADULT; ALBUMIN DIALYSIS; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEAT STROKE; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MALE; MUSHROOM; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SATISFACTION; PRIORITY JOURNAL; RECIPIENT; THERAPY EFFECT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT WITHDRAWAL;

ADULT; ALBUMINS; COHORT STUDIES; EXTRACORPOREAL CIRCULATION; FEMALE; FRANCE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES; SORPTION DETOXIFICATION; TIME FACTORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 71949125030     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00708.x     Document Type: Article

References (35)

1. Kantola T, Koivusalo AM, Höckerstedt K, Isoniemi H. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transplant Int 2008 32 : 1817 1825.
2. Camus C, Lavoue S, Gacouin A et al. Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 2006 32 : 1817 1825.
3. Awad SS, Swaniker F, Magee J, Punch J, Bartlett RH. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001 130 : 354 362.
4. Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003 38 : 24 31.
5. Bernuau J, Samuel D, Durand F et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal: a prospective study. Hepatology 1991 14 : 49A. Abstract.
6. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989 97 : 439 445. (Pubitemid 19192181)
7. Bismuth H, Samuel D, Castaing D et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995 222 : 109 119.
8. Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002 359 (9306 558 563. (Pubitemid 34178437)
9. Wiesner RH. MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease. Liver Transpl 2004. 10 (Suppl. 2 S17 22.
10. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993 270 : 2957 2963. Erratum in: JAMA 1994;271(17):1321.
11. Jalan R. Acute liver failure: current management and future prospects. J Hepatol 2005 42 (Suppl. 1 S115 23.
12. Khuroo MS, Khuroo MS, Farahat KLC. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis. Liver Transpl 2004 10 : 1099 1106.
13. Pollock KJ, Lee AC, Hayes PC. A randomized controlled trial or the use of albumin dialysis (MARS) in fulminant hepatic failure due to paracetamol poisoning. Gut 2004 53 (Suppl. III A13, Abstract 047.
14. Demetriou AA, Brown RS, Busuttil RW et al. Prospective randomized multicenter controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004 239 : 660 670.
15. Lahdenperä A, Koivusalo AM, Vakkuri A, Hockerstedt K, Isoniemi H. Value of albumin dialysis therapy in severe liver insufficiency. Transpl Int 2005 17 : 717 723.
16. McIntyre CW, Fluck RJ, Freeman JG, Lambie SH. Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction. Clin Nephrol 2002 58 : 376 383.
17. Covic A, Goldsmith DJ, Gusbeth-Tatomir P et al. Successful use of Molecular Absorbent Regenerating System (MARS) dialysis for the treatment of fulminant hepatic failure in children accidentally poisoned by toxic mushroom ingestion. Liver Int 2003 23 (Suppl. 3 21 7.
18. Sen S, Felldin M, Steiner C et al. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Liver Transpl 2002 8 : 962 967.
19. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Müllhaupt B, Renner EL. Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 2007 27 : 475 484.
20. Faybik P, Bacher A, Kozek-Langenecker SA et al. Molecular adsorbent recirculating system and hemostasis in patients at risk of bleeding: an observational study. Crit Care 2006 10 : R24.
21. Tan HK, Yang WS, Chow P, Lui HF, Choong HL, Wong KS. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system. Artif Organs 2007 31 : 191 199.
22. Yang WS, Tan HK, Lui HF, Chow PK, Choong HL, Wong KS. Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin. Artif Organs 2008 32 : 411 416.
23. Boyle M, Kurtovic J, Bihari D, Riordan S, Steiner C. Equipment review: the molecular adsorbents recirculating system (MARS). Crit Care 2004 8 : 280 286.
24. Awad SS, Rich PB, Kolla S et al. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin. ASAIO J 1997 43 : 745 749.
25. Sen S, Jalan R, Williams R. Extracorporeal albumin dialysis in acute-on-chronic liver failure: will it stand the test of time? Hepatology 2002 36 : 1014 1016.
26. Isoniemi H, Koivusalo AM, Repo H, Ilonen I, Hockerstedt K. The effect of albumin dialysis on cytokine levels in acute liver failure and need for liver transplantation. Transplant Proc 2005 37 : 1088 1090.
27. Schmidt LE, Wang LP, Hansen BA, Larsen FS. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 2003 9 : 290 297.
28. Sorkine P, Ben Abraham R, Szold O et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 2001 29 : 1332 1336. (Pubitemid 32641793)
29. Sen S, Rose C, Ytrebo LM et al. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study. Crit Care Med 2006 34 : 158 164. (Pubitemid 43032393)
30. Sen S, Davies NA, Mookerjee RP et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004 10 : 1109 1119.
31. Novelli G, Rossi M, Pretagostini R et al. A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion. Liver Int 2003 23 (Suppl. 3 10 15.
32. Stange J, Mitzner SR, Risler T et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999 23 : 319 330.
33. Stange J, Mitzner SR, Klammt S et al. Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 2000 6 : 603 613.
34. Lucchi L, Ligabue G, Marietta M et al. Activation of coagulation during hemodialysis: effect of blood lines alone and whole extracorporeal circuit. Artif Organs 2006 30 : 106 110.
35. Dabos KJ, Newsome PN, Parkinson JA et al. Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure. Transplantation 2004 77 : 200 205.